LB Pharmaceuticals Inc Common Stock (LBRX) vs Savara Inc. (SVRA)
A side-by-side comparison of LB Pharmaceuticals Inc Common Stock and Savara Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LBRX
LB Pharmaceuticals Inc Common Stock
$34.32HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
SVRA
Savara Inc.
$4.66HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT
Total return — LBRX vs SVRA
growth of $100 · dividends reinvested · last 1yLBRX +100.1% (+100.1%/yr)SVRA +24.8% (+24.8%/yr)LBRX compounded faster over this window
LBRX SVRA
LBRX vs SVRA: by the numbers
- •LBRX is the larger company ($984M vs $955M market cap).
Metrics side by side
Valuation
| Metric | LBRX | SVRA |
|---|---|---|
| P/B ratio | 2.96 | 6.65 |
Profitability
| Metric | LBRX | SVRA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -25.78% | -96.97% |
| ROIC | -28.14% | -82.30% |
Growth (annualized)
| Metric | LBRX | SVRA |
|---|---|---|
| Total return CAGR (5Y) | N/A | 29.75% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.